3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Carcinoma, Renal Cell
4
Carcinoma, Hepatocellular
4
Melanoma
2
Endometrial Neoplasms
2
von Hippel-Lindau Disease
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Hematologic Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Clear-cell metastatic renal cell carcinoma
1
Cirrhosis, Familial, with Pulmonary Hypertension
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Adenoid Cystic
1
Brain Neoplasms
1
Bone Neoplasms
1
Advanced Malignancies
1
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
1
Adenocarcinoma
1
Interventions
Magnetic Resonance Spectroscopy
13
Temozolomide
12
Specimen Handling
8
X-Rays
7
Biopsy
7
Nuclear Medicine Department, Hospital
6
Radiation
5
Phantoms, Imaging
5
trametinib
4
erdafitinib
4
dabrafenib
4
ulixertinib
3
larotrectinib
3
Radiotherapy
3
tipifarnib
2
selpercatinib
2
palbociclib
2
olutasidenib
2
olaparib
2
ivosidenib
2
ensartinib
2
binimetinib
2
Nivolumab
2
D2C7-(scdsFv)-PE38KDEL
2
vorasidenib
1
veliparib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tazemetostat
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
lenvatinib
×
30 days
×
Clear all
No trials found.